Puhlmann Markus
Known title: Chief Medical OfficerCIK: 0001965071
Puhlmann Markus's purchase track record
Puhlmann Markus has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/24/2024 | CATX | $140K | +244.9% | +161.6% | +11.5% |
| 12/15/2023 | CATX | $189K | +296.3% | +296.3% | +15.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CATX | ▲ Buy | Open Market | 280,000 | $140K | 1/24/2024 | View on chart |
| CATX | ▲ Buy | Open Market | 400,000 | $137K | 12/19/2023 | View on chart |
| CATX | ▲ Buy | Open Market | 60,419 | $15K | 12/18/2023 | View on chart |
| CATX | ▲ Buy | Open Market | 135,006 | $36K | 12/15/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
CATX included in pre-market movers list
Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.
CATX included in pre-market movers list. Perspective Therapeutics was listed among stocks moving lower in Monday's pre-market session. The company is currently trading near its 52-week low, with an RSI of 32.3 indicating oversold conditions. Analysts maintain an average price target of $12.29, which is significantly higher than the current market price.